{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:58:42Z","timestamp":1793717922729,"version":"4.6.1"},"publisher-location":"Singapore","reference-count":10,"publisher":"Springer Singapore","isbn-type":[{"value":"9789813292703","type":"print"},{"value":"9789813292710","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-32-9271-0_10","type":"book-chapter","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T14:02:56Z","timestamp":1575036176000},"page":"193-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Standardized Treatment Strategy for Depressive Disorder"],"prefix":"10.1007","author":[{"given":"Zuowei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiancang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,30]]},"reference":[{"key":"10_CR1","doi-asserted-by":"crossref","unstructured":"Cipriani A, Koesters M, Furukawa TA, Nos\u00e8 M, Purgato M, Omori IM, Trespidi C, Barbui C (2012) Duloxetine versus other anti-depressive agents for depression. Cochrane Database Syst Rev 10:CD006533","DOI":"10.1002\/14651858.CD006533.pub2"},{"issue":"10128","key":"10_CR2","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391(10128):1357\u20131366","journal-title":"Lancet"},{"issue":"11","key":"10_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.7326\/0003-4819-155-11-201112060-00009","volume":"155","author":"G Gartlehner","year":"2011","unstructured":"Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN (2011) Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med 155(11):772\u2013785","journal-title":"Ann Intern Med"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/mp.2015.53","volume":"21","author":"F Hieronymus","year":"2016","unstructured":"Hieronymus F, Emilsson JF, Nilsson S, Eriksson E (2016) Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psychiatry 21:523\u2013530","journal-title":"Mol Psychiatry"},{"key":"10_CR5","doi-asserted-by":"crossref","unstructured":"Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P et al (2016) Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section\u00a03. Pharmacological Treatments. Can J Psychiatry\/La Rev Can Psychiatr 1\u201321","DOI":"10.1177\/0706743716659417"},{"issue":"13","key":"10_CR6","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.2147\/NDT.S131438","volume":"4","author":"A Kuga","year":"2017","unstructured":"Kuga A, Tsuji T, Hayashi S, Matsubara M, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T (2017) An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis. Neuropsychiatr Dis Treat 4(13):2105\u20132114","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"9","key":"10_CR7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1177\/0706743716659416","volume":"61","author":"Raymond W. Lam","year":"2016","unstructured":"Lam RW, McIntosh D, Wang J, Enns MW, Kolivakis T, Michalak EE, Sareen J, Song WY, Kennedy SH, MacQueen GM, Milev RV, Parikh SV, Ravindran AV (2016) CANMAT depression work group. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section\u00a01. Disease burden and principles of care. Can J Psychiatry 61(9):510\u2013523","journal-title":"The Canadian Journal of Psychiatry"},{"key":"10_CR8","volume-title":"Practice guideline for prevention and treatment of depressive disorder (in Chinese)","author":"LJ Li","year":"2015","unstructured":"Li LJ, Ma X (2015) Practice guideline for prevention and treatment of depressive disorder (in Chinese). Chin Soc Psychiatry, Beijing"},{"issue":"4","key":"10_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.9758\/cpn.2017.15.4.361","volume":"15","author":"B Nam","year":"2017","unstructured":"Nam B, Bae S, Kim SM, Hong JS, Han DH (2017) Comparing the effects of bupropion and escitalopram on excessive internet game play in patients with major depressive disorder. Clin Psychopharmacol Neurosci 15(4):361\u2013368","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10_CR10","doi-asserted-by":"publisher","unstructured":"Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, Churchill R, Furukawa TA (2011) Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev (12):CD006528. \nhttps:\/\/doi.org\/10.1002\/14651858.cd006528","DOI":"10.1002\/14651858.cd006528"}],"container-title":["Advances in Experimental Medicine and Biology","Depressive Disorders: Mechanisms, Measurement and Management"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-32-9271-0_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T14:08:20Z","timestamp":1583590100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-32-9271-0_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789813292703","9789813292710"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-981-32-9271-0_10","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"30 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}